Article Details

Ambrx tries another IPO as it chases down HER2 rivals

Retrieved on: 2021-06-16 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

Ambrx tries another IPO as it chases down HER2 rivals. View article details on hiswai:

Excerpt

... previously treated with other HER2 drugs including Roche's Kadcyla (trastuzumab emtansine), AstraZeneca/Daiichi Sankyo's Enhertu (trastuzumab ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo